We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

467 hedge funds and large institutions have $5.28B invested in Bioverativ Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 467 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $21.4M | Put options by funds: $14.1M

Holders
467
Holders Change
+467
Holders Change %
–
% of All Funds
11.63%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
467
Increased
–
Reduced
–
Closed
–
Calls
$21.4M
Puts
$14.1M
Net Calls
+$7.29M
Net Calls Change
+$7.29M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$433M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$429M
3
VH
ValueAct Holdings
California
+$418M
4
Primecap Management
Primecap Management
California
+$381M
5
HM
HealthCor Management
New York
+$246M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
JG
151
Jefferies Group
New York
$1.96M +$1.77M +35,949 New
EFEM
152
Eos Focused Equity Management
New York
$1.92M +$1.74M +35,242 New
N
153
Nuveen
North Carolina
$1.76M +$1.59M +32,238 New
PP
154
Prudential plc
United Kingdom
$1.75M +$1.58M +32,088 New
RFS
155
Rockefeller Financial Services
New York
$1.73M +$1.56M +31,731 New
NI
156
Numeric Investors
Massachusetts
$1.71M +$1.55M +31,455 New
RPAM
157
Rhenman & Partners Asset Management
Sweden
$1.69M +$1.53M +31,000 New
GT
158
Glenmede Trust
Pennsylvania
$1.67M +$1.51M +30,669 New
HCM
159
Highbridge Capital Management
New York
$1.63M +$1.48M +30,000 New
OC
160
Oppenheimer & Co
New York
$1.51M +$1.37M +27,784 New
LSERS
161
Louisiana State Employees Retirement System
Louisiana
$1.49M +$1.34M +27,300 New
TD Asset Management
162
TD Asset Management
Ontario, Canada
$1.45M +$1.31M +26,662 New
HT
163
HAP Trading
New York
$1.43M +$1.3M +26,306 New
GH
164
GAM Holding
Switzerland
$1.42M +$1.28M +26,050 New
ZIG
165
Zurich Insurance Group
Switzerland
$1.37M +$1.24M +25,238 New
CPIM
166
Columbia Partners Investment Management
Virginia
$1.37M +$1.24M +25,169 New
Natixis Advisors
167
Natixis Advisors
Massachusetts
$1.35M +$1.22M +24,724 New
Group One Trading
168
Group One Trading
Illinois
$1.32M +$1.2M +24,283 New
AAM
169
Auxier Asset Management
Oregon
$1.32M +$1.19M +24,179 New
SF
170
Synovus Financial
Georgia
$1.3M +$1.18M +23,861 New
DCM
171
Dupont Capital Management
Delaware
$1.27M +$1.15M +23,400 New
BF
172
BOK Financial
Oklahoma
$1.26M +$1.14M +23,225 New
CL
173
CIM LLC
New York
$1.26M +$1.14M +23,239 New
FWIA
174
Fort Washington Investment Advisors
Ohio
$1.26M +$1.14M +23,140 New
PIA
175
Piedmont Investment Advisors
North Carolina
$1.25M +$1.13M +22,921 New
5 6
7
8 9

BIVV Hedge Fund Activity: Q1 2017 in Review

467 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2017, worth a combined $5.28B.

Buyers outnumbered sellers: 467 funds opened new BIVV positions and 0 closed out — a net gain of 467 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $433M.

  • 467 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $5.28B of Bioverativ Inc. Common Stock stock for Q1 2017.
  • 467 funds opened new Bioverativ Inc. Common Stock positions in Q1 2017 and 0 closed out, a net change of +467 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $433M added.

Based on aggregated 13F filings for Q1 2017.